Earnings

Thermo Fisher Scientific Raises FY2026 Adj EPS Guidance from $24.93-$25.33 to $25.13-$25.43 vs $25.14 Est; Raises FY2026 Sales Guidance from $47.400B-$48.100B to $47.700B-$48.200B vs $47.885B Est

Oct 21, 2026 · 08:04 AM ET· updated 1h ago

Thermo Fisher Scientific (NYSE:TMO) raises FY2026 Adj EPS guidance from $24.93-$25.33 to $25.13-$25.43 vs $25.14 analyst estimate. Raises FY2026 sales outlook from $47.400 billion-$48.100 billion to $47.700

Why It Matters

Thermo Fisher raised its profit and sales forecasts for next year slightly higher. This shows the company feels confident about its business growing as planned.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

TMO670.00

-17.37 (-2.53%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.